Livecareer-Resume
Jessica
Claire
resumesample@example.com
(555) 432-1000,
, , 100 Montgomery St. 10th Floor
:
Professional Summary

Highly motivated and committed Medical Assistant with proven history of superior performance at individual, team and organizational levels. Strong ability to multitask and prioritize workloads with little or no supervision. Detail-oriented professional looking to bring medical background and team-building skills to deadline-driven environment.

Skills
  • Treatment Room Preparation
  • Medication Administration
  • Electronic Charting
  • Social Perceptiveness
  • Pharmacy Relations
  • Multi-line Telephone System Operation
  • Patient Relations
  • Procedure Assistance
  • Appointment Scheduling
Education
Georgia State University Atlanta, GA Expected in Associate of Science : Health Sciences - GPA :
Georgia Medical Institute-Dekalb Atlanta, GA Expected in : Medical Assisting - GPA :
Certifications

IATA

Dangerous Goods Training

Work History
Cci Health & Wellness Services - Medical Assistant
Greenbelt, MD, 04/2021 - Present
  • Communicated clearly and effectively with patients to verify information, determine purpose of visit and record medical history.
  • Conducted preliminary evaluations, including measuring weight, temperature and blood pressure, and documented results with accuracy.
  • Directed patients to exam rooms, fielded questions and prepared for physician examinations.
  • Perform venipuncture.
  • Sanitized, restocked and organized exam rooms and medical equipment.
  • Called and faxed pharmacies to submit prescriptions and refills.
  • Obtain Prior authorization for medication.
  • Performed clerical duties, such as obtaining authorization for office visit , answering phones, scheduling appointments, and filing.
Marshfield Clinic - Care Team Coordinator
Cumberland, WI, 08/2020 - 04/2021
  • Acted as main point of contact for patients, doctors and hospital staff by closely reviewing medical charts and maintaining high levels of communication.
  • Worked closely with patients to deliver excellent and direct individualized patient care.
  • Worked with patients to schedule, appointments for office visits, tests and procedures.
  • Completed documentation of care, hospital actions and patient activities.
  • Maintained confidentiality of patient data and condition at all times to safeguard health information.
  • Upheld confidentiality requirements and regulatory compliance guidelines in all areas.
  • Delivered excellent patient experiences and direct care.
Atlanta ID Group - Medical Assistant /Clinical Research Coordinator
City, STATE, 11/2008 - 06/2020
  • Coordinated day-to-day clinic activities, including assignment of duties to experienced staff and orientation and training of less experienced clinic staff in specific clinic operations and procedures.
  • Kept medical supplies in sufficient stock by monitoring levels and submitting replenishment orders before depleted.
  • Documented patient care with electronic medical record and distributed relevant information to other medical providers to update diagnostic and treatment plans.
  • Counseled patients via telephone according to established guidelines and protocols, advising on provider-established plans of care.
  • Scheduled appointments for patients not requiring emergency services but needing examination from provider and consulting directly with provider as needed.
  • Demonstrated ability to advocate for and strive to protect health, safety, and rights of patient.
  • Followed all personal and health data procedures to effectively comply with HIPAA laws and prevent information breaches.
  • Processed all FMLA/Disability forms.
  • Collaborated with medical and administrative personnel to maintain patient-focused, engaging and compassionate environment.
  • Assisted 6 MD's and 6 PA's to ensure optimal patient care.
  • Conducted preliminary evaluations, including measuring weight, temperature and blood pressure, and documented results with accuracy.
  • Performed venipuncture, EKG's, administered vaccinations , antibiotics , and assisted with minor wound care.
  • Enhanced patient outcomes by providing knowledgeable education on procedures, medications and other physician instructions.
  • Maintained research data, participant fields, regulatory binders and study databases.
  • Performed administrative support duties.
  • Assisted with regulatory binders and quality assurance and quality control procedures.
  • Worked with principal investigator and sponsors to facilitate daily trial activities and comply with research protocols.
  • Followed informed consent processes and maintained records.
  • Maintained compliance with protocols covering patient care and clinical trial operations.
  • Screened patient records, databases and physician referrals to identify prospective candidates for research studies.
  • Participated in initiation visits and investigator meetings, implementing trials in accordance with study timelines and budgets.
  • Gathered, processed and shipped lab specimens.
  • Carried out day-day-day duties accurately and efficiently.

Research Experience

Medical Reasearch
• GS-US-292-0104: A Phase 3, Randomized, Double-Blind Study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide Versus
Elvitegravir/Cobicistat//Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment – Naïve Adults. (Research Coordinator, 2013)
• GS-US-292-0109: A Phase 3, Open-Label Study to Evaluate Switching from a TDF- Containing Combination Regimen to a TAF- Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1, Positive Subjects. (Research Coordinator, 2013)
• GS-US-292-0\A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide Versus
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults. (Research Coordinator, 2013)
• GS-US-292-0119: A Phase 3 Open-Label Study to Evaluate Switching from Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alefenamide (E/C/F/TAF) Single Tablet Regimen (STR) plus Darunavir (DRV) in Treatment Experienced HIV-1Positive Adults. (Research Coordinator, 2013)
• GS-US-311-1089: A Phase 3, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Positive Subjects who are Virologically Suppressed on Regimens containing FTC/TDF. (Research Coordinator, 2014)
• GS-US-366-1160: A Phase 3b, Randomized, Double-Blind Study to Evaluate Switching from a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivarine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Supressed, HIV-1Infected Subjects. (Research Coordinator, 2015)
• GS-US-366-1216: A Phase 3b, Randomized, Double-Blind Switch Study to Evaluate the Safety and Efficacy of emtricitabine/Rilpivarine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Subjects who are Virologically Supressed on Emtricitabine/Rilpivarine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF). (Research Coordinator, 2015)
• GS-US-311-1717: A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects who are Virologically Supressed on Regimens Containing ABC/3TC. (Research Coordinator, 2015)
• GS-US-380-1489: A Phase 3, Randomized, double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/ Emtricitabine/Tenofovir Alafenamide Versus Abacavir/ Dolutegravir/ Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults. (Research Coordinator, 2016)
• GS-US-412-2055: A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine/Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are at Risk of HIV-1 Infection. (Research Coordinator, 20016)itabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment – Naïve Adults. (Research Coordinator, 2013)

· GS-US-292-0109: A Phase 3, Open-Label Study to Evaluate Switching from a TDF- Containing Combination Regimen to a TAF- Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1, Positive Subjects. (Research Coordinator, 2013)

· GS-US-292-0111: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide Versus

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults. (Research Coordinator, 2013)

· GS-US-292-0119: A Phase 3 Open-Label Study to Evaluate Switching from Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alefenamide (E/C/F/TAF) Single Tablet Regimen (STR) plus Darunavir (DRV) in Treatment Experienced HIV-1Positive Adults. (Research Coordinator, 2013)

· GS-US-311-1089: A Phase 3, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Positive Subjects who are Virologically Suppressed on Regimens containing FTC/TDF. (Research Coordinator, 2014)

· GS-US-366-1160: A Phase 3b, Randomized, Double-Blind Study to Evaluate Switching from a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivarine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Supressed, HIV-1Infected Subjects. (Research Coordinator, 2015)

· GS-US-366-1216: A Phase 3b, Randomized, Double-Blind Switch Study to Evaluate the Safety and Efficacy of emtricitabine/Rilpivarine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Subjects who are Virologically Supressed on Emtricitabine/Rilpivarine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF). (Research Coordinator, 2015)

· GS-US-311-1717: A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects who are Virologically Supressed on Regimens Containing ABC/3TC. (Research Coordinator, 2015)

· GS-US-380-1489: A Phase 3, Randomized, double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/ Emtricitabine/Tenofovir Alafenamide Versus Abacavir/ Dolutegravir/ Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults. (Research Coordinator, 2016)

· GS-US-412-2055: A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine/Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are at Risk of HIV-1 Infection. (Research Coordinator, 20016)

By clicking Customize This Resume, you agree to our Terms of Use and Privacy Policy

Disclaimer

Resumes, and other information uploaded or provided by the user, are considered User Content governed by our Terms & Conditions. As such, it is not owned by us, and it is the user who retains ownership over such content.

How this resume score
could be improved?

Many factors go into creating a strong resume. Here are a few tweaks that could improve the score of this resume:

84Good

resume Strength

  • Formatting
  • Length
  • Personalization
  • Strong Summary
  • Target Job
  • Word Choice

Resume Overview

School Attended

  • Georgia State University
  • Georgia Medical Institute-Dekalb

Job Titles Held:

  • Medical Assistant
  • Care Team Coordinator
  • Medical Assistant /Clinical Research Coordinator

Degrees

  • Associate of Science

By clicking Customize This Resume, you agree to our Terms of Use and Privacy Policy

*As seen in: